Haemonetics (HAE) Misses Q4 EPS by 5c; Guides FY16 EPS
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.84 -0.08%
EPS Growth %: 0.0%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.47, $0.05 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $226.5 million versus the consensus estimate of $239.2 million.
Haemonetics sees FY2015 EPS of $1.98-$2.08, versus the consensus of $2.09.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- CBRE Global Real Estate Income Fund adjusts September distribution after split
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
